Details
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Syneron Bio $150M Series BExcalipoint Therapeutics $27.7M Seed+New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Emversity $30M Series AGIVA ₹5.3B Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.